Key Developments: Teleflex Inc (TFX.N)

TFX.N on New York Stock Exchange

106.97USD
4:00pm EDT
Price Change (% chg)

$0.32 (+0.30%)
Prev Close
$106.65
Open
$106.62
Day's High
$107.04
Day's Low
$106.23
Volume
15,427
Avg. Vol
44,770
52-wk High
$109.57
52-wk Low
$74.50

Search Stocks

Latest Key Developments (Source: Significant Developments)

Teleflex Inc announces quarterly dividend
Monday, 5 May 2014 07:00am EDT 

Teleflex Inc:Declares quarterly cash dividend of 0.34 per share of common stock.Dividend is payable June 16 to shareholders of record at close of business on May 15.  Full Article

Teleflex Inc gives FY 2014, 2016 charge outlook; reaffirms FY 2014 outlook
Wednesday, 30 Apr 2014 07:00am EDT 

Teleflex Inc:Says it estimates that it will incur aggregate pre-tax charges in connection with these restructuring activities of about $42-$53 mln, of which it expects about $22-$23 mln will be incurred in FY 2014 and most of the balance will be incurred prior to the end of FY 2016.Expects FY 2014 GAAP revenue growth in the range of 6.0-8.0 pct.Expects FY 2014 constant currency revenue growth in the range of 7.0-9.0 pct.Expects FY 2014 diluted earnings per share in the range of $3.40-$3.55.Expects FY 2014 adjusted diluted earnings per share in the range of $5.35-$5.55.Reported revenue of $1.696 bln in FY 2013.FY 2014 revenue of $1.813 bln , EPS of $5.51 - Thomson Reuters I/B/E/S.  Full Article

Teleflex Inc highlights ARROWg+ard Blue PLUS Antimicrobial Central Venous Catheter (CVC) Study
Tuesday, 25 Mar 2014 09:00am EDT 

Teleflex Inc:Newly published research has reaffirmed that ARROW Central Venous Catheter (CVC) with ARROWg+ard Blue PLUS Technology reduces the incidence of catheter-related bloodstream infections (CRBSIs).Reduces direct costs related to treatment of these potentially deadly infections.ARROWg+ard Blue PLUS Technology protects catheter surfaces both intra- and extraluminally with chlorhexidine/silver sulfadiazine.Authors tested CVCs to determine which was more cost effective, including cost of treating any associated infections.Study involved patients admitted to ICU of the Hospital Universitario de Canarias in Tenerife, Spain, who received one or more internal jugular venous catheters.It examined a total of 636 catheters and 3,271 catheter days. Each patient's physician made the decision about whether to use a protected or unprotected catheter.  Full Article

Teleflex Inc announces quarterly dividend
Friday, 21 Feb 2014 07:30am EST 

Teleflex Inc:Declares a quarterly cash dividend of $0.34 per share of common stock.Says the dividend is payable Mar.14 to shareholders of record at the close of business on Mar. 4.  Full Article

Teleflex Inc. reaffirms FY 2014 financial guidance
Friday, 21 Feb 2014 07:00am EST 

Teleflex Inc:Reaffirms FY 2014 financial estimates.Expects FY 2014 constant currency revenue growth between 7 pct. and 9 pct.Forecasts FY 2014 diluted earnings per share attributable to common shareholders of $3.60 to $3.75.Forecasts FY 2014 adjusted diluted earnings per share (EPS) of $5.35 to $5.55.Reported revenue of $1.684 bln in fiscal 2013.FY 2014 revenue of $1.805 bln and EPS of $5.49 - Thomson Reuters I/B/E/S.  Full Article

Teleflex Inc launches the Rusch DispoLED Laryngoscope Handle
Friday, 14 Feb 2014 07:00am EST 

Teleflex Inc:Announces the launch of the Rusch DispoLED Single-Use Fiber Optic Laryngoscope Handle _ a cost-neutral way to combat cross-contamination infection risk during intubation.Says the Rusch DispoLED Laryngoscope Handle is packaged individually in a preformed tray to protect the integrity of the light source and preloaded batteries.Says with a validated three-year shelf life, the Rusch DispoLED Laryngoscope Handle can be safely stored for long periods and is ready to use out of the package.  Full Article

Teleflex Inc lowers FY 2013 revenue outlook; Reaffirms FY 2013 EPS outlook; gives FY 2014 outlook
Tuesday, 17 Dec 2013 09:00am EST 

Teleflex Inc:Sees FY 2013 constant currency revenue growth between 8.0 pct to 8.7 pct.Sees FY 2013 adjusted diluted earnings per share (EPS) in the range of $4.85 -$5.00.Sees FY 2014 constant currency revenue growth between 7.0 pct to 9.0 pct.Sees FY 2014 adjusted diluted EPS in the range of $5.35 - $5.55.Says it reported revenue of $1.551 bln in FY 2012.FY 2013 revenue of $1.692 bln, EPS of $4.94 - Thomson Reuters I/B/E/S.FY 2014 revenue of $1.772 bln, EPS of $5.47 - Thomson Reuters I/B/E/S.  Full Article

Teleflex Inc completes acquisition of Vidacare Corporation
Monday, 2 Dec 2013 05:00pm EST 

Teleflex Inc:Says it has completed acquisition of Vidacare Corporation, the provider of intraosseous, or inside the bone, access devices.  Full Article

Teleflex Inc Announces Quarterly Dividend
Wednesday, 30 Oct 2013 07:30am EDT 

Teleflex Inc announced that its Board of Directors declared a quarterly cash dividend of $0.34 per share of common stock. The dividend is payable December 13, 2013 to shareholders of record at the close of business on November 15, 2013.  Full Article

Teleflex Inc Lowers FY 2013 Revenue Guidance; Raises FY 2013 EPS Guidance
Wednesday, 30 Oct 2013 07:00am EDT 

Teleflex Inc announced that for fiscal 2013, it expects constant currency revenue growth between 8.5% and 10%. This compares to the previously provided constant currency revenue growth range of between 10% and 12%. Adjusted diluted earnings per share (EPS) in the range of $4.85 to $5.00. This compares to the previously provided adjusted diluted earnings per share range of $4.70 to $4.90. The Company reported revenue of $1.551 billion in fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $1.70 billion and EPS of $4.85 for fiscal 2013.  Full Article

DIARY-U.S. MEETINGS/WEEK AHEAD

THOMSON REUTERS, Apr 29,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Rese

Search Stocks